73 reports

In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Europe Version

216 pages • By Howe Sound Research

“In Vitro Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially...

4541 4995 3860
Apr 2017

In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version

263 pages • By Howe Sound Research

“In Vitro Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially...

5450 5995 4633
Apr 2017

Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 - Europe Version

216 pages • By Howe Sound Research

“Clinical Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially...

4541 4995 3860
Apr 2017

Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version

263 pages • By Howe Sound Research

“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics....

5450 5995 4633
Apr 2017

Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 - Global Version

263 pages • By Howe Sound Research

“Clinical Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Date: April 3, 2017 Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion...

5450 5995 4633
Apr 2017

Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Europe Version

216 pages • By Howe Sound Research

“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics....

4541 4995 3860
Apr 2017

Global Biomarker Partnering Terms and Agreements 2010-2017: Deal trends, players and financials

658 pages • By Currentpartnering

Summary The Global Biomarker Partnering Terms and Agreements 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies Description The Global Biomarker...

2723 2995 2314
Apr 2017

Global Companion Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts

248 pages • By Currentpartnering

Summary The Global Companion Diagnostics Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies Description The Global Companion Diagnostics Partnering 2010-2017...

2723 2995 2314
Apr 2017

Biomarkers Enabling Diabetes and Obesity Management

68 pages • By Frost & Sullivan

Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape....

4500 4950 3825
Mar 2017

Non-alcoholic steatohepataitis (NASH) Pipeline Analysis

144 pages • By IQ4I Research & Consultancy Pvt. Ltd

“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering...

3273 3600 2782
Feb 2017

Asia Pacific Cancer Biomarkers Market - Growth, Trends and Forecasts (2017 - 2022)

134 pages • By Mordor Intelligence LLP

The Asia-Pacific Cancer Biomarkers market is expected to reach USD XX million by 2020 growing at a CAGR of 16% from 2015 to 2021. Cancer biomarkers are substances that is an indicative of the presence of cancer in the body. Cancer biomarkers are secreted by a tumor or specific response of the body to the presence of Cancer. These are the substance...

3500 3850 2975
Feb 2017

Biomarkers Market by Product, Type, Disease Indication, Application - Global Forecast to 2021

160 pages • By MarketsandMarkets

The global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries,...

5045 5650 4338
Feb 2017

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

439 pages • By Currentpartnering

Summary The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies. Description The Global Joint Venture...

1814 1995 1542
Feb 2017

Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2017

129 pages • By Currentpartnering

Summary The Global Pharmacogenomics Partnering Terms & Agreements 2010 to 2017 report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Pharmacogenomics Partnering...

2723 2995 2314
Feb 2017

Global Molecular Diagnostics 2010-2017: Deal trends, players, financials and forecasts

495 pages • By Currentpartnering

Summary Global Molecular Diagnostics Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the molecular diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Molecular Diagnostics Partnering 2010-2017...

2723 2995 2314
Feb 2017

Global Cancer Biomarkers Market - Growth, Trends and Forecasts (2017 - 2022)

211 pages • By Mordor Intelligence LLP

The global biomarkers market was worth USD $ 13.16 billion in 2011 and it is expected to reach USD 30.2 billion by 2019 at a CAGR of 14.60%. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Oncology biomarkers offers high speed, non invasive cancer diagnosis and believe...

3864 4250 3284
Jan 2017

Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

152 pages • By Transparency Market Research

Global Non-alcoholic Steatohepatitis Biomarker Market: Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH is an advanced form of NAFLD where the liver inflammation occurs owing to fat deposition in liver. The fat accumulation...

5268 5795 4478
Jan 2017

The World Market for Personalized Medicine Tests for Cancer

140 pages • By Kalorama Information

The World Market for Personalized Medicine Tests for Cancer This report, Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW)....

2723 2995 2314
Jan 2017

US Cancer Biomarkers Market - Growth, Trends and Forecasts (2017 - 2022)

107 pages • By Mordor Intelligence LLP

United States leads the global market for Biomarkers. Growing at a robust compounded annual growth rate of 18.8% during the period (2017 - 2022), the global market is projected to touch US $63.2 billion. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Oncology biomarkers...

2955 3250 2511
Jan 2017

Global Genomics Biomarkers Market 2017-2021

83 pages • By Infiniti Research Limited

About Genomics Biomarkers A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of...

3398 3500 2922
Jan 2017

Europe Cancer Biomarkers Market - Growth, Trends and Forecasts (2017 - 2022)

134 pages • By Mordor Intelligence LLP

Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Oncology biomarkers offers high speed, non invasive cancer diagnosis and believe to enhance cancer detection and screening. Major factors for the Europe biomarkers market are streamlined drug delivery process, noninvasive...

3500 3850 2975
Jan 2017

Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016

307 pages • By GlobalData

Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016" provides an overview of Inborn Gene or Chromosome Alterations currently in pipeline stage. The...

3636 4000 3091
Dec 2016

Cancer/Tumor Profiling Market by Application, Technique,Technology- Forecast to 2021

159 pages • By MarketsandMarkets

The global Cancer/Tumor Profiling market is poised to reach USD 61.87 billion by 2021 from USD 25.82 billion in 2016, at a CAGR of 19.1% from 2016 to 2021. Increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research are the major factors driving the growth of the...

5045 5650 4338
Dec 2016

Global Cardiac Biomarker Market Analysis 2016 - Forecast to 2022

148 pages • By Hoovers Research

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a...

4136 4550 3516
Dec 2016

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

537 pages • By GlobalData

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Breast Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive...

3636 4000 3091
Dec 2016

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

470 pages • By GlobalData

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Prostate Cancer Diagnostic Tests currently in pipeline stage. The report provides...

3636 4000 3091
Dec 2016

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2016

396 pages • By GlobalData

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Immunochemistry Analyzers currently in pipeline stage. The report provides comprehensive...

3636 4000 3091
Dec 2016

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

175 pages • By GlobalData

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Pancreatic Cancer Diagnostic Tests currently in pipeline stage. The report provides...

3636 4000 3091
Dec 2016

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

157 pages • By GlobalData

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Leukemia Diagnostic Tests currently in pipeline stage. The report provides comprehensive...

3636 4000 3091
Dec 2016

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

467 pages • By GlobalData

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive...

3636 4000 3091
Dec 2016